Harbor Investment Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29K | Buy |
74
+56
| +311% | +$7.03K | ﹤0.01% | 898 |
|
|
2025
Q1 | $2.46K | Hold |
18
| – | – | ﹤0.01% | 1060 |
|
|
2024
Q4 | $2.75K | Sell |
18
-74
| -80% | -$11.3K | ﹤0.01% | 1021 |
|
|
2024
Q3 | $17.8K | Sell |
92
-18
| -16% | -$3.49K | ﹤0.01% | 759 |
|
|
2024
Q2 | $25.5K | Buy |
110
+2
| +2% | +$464 | ﹤0.01% | 704 |
|
|
2024
Q1 | $23.3K | Buy |
108
+29
| +37% | +$6.25K | ﹤0.01% | 716 |
|
|
2023
Q4 | $20.4K | Buy |
79
+12
| +18% | +$3.11K | ﹤0.01% | 712 |
|
|
2023
Q3 | $17.2K | Hold |
67
| – | – | ﹤0.01% | 717 |
|
|
2023
Q2 | $19.1K | Hold |
67
| – | – | ﹤0.01% | 907 |
|
|
2023
Q1 | $18.6K | Hold |
67
| – | – | ﹤0.01% | 923 |
|
|
2022
Q4 | $18.6K | Hold |
67
| – | – | ﹤0.01% | 912 |
|
|
2022
Q3 | $18K | Hold |
67
| – | – | ﹤0.01% | 926 |
|
|
2022
Q2 | $14K | Sell |
67
-25
| -27% | -$5.22K | ﹤0.01% | 961 |
|
|
2022
Q1 | $19K | Buy |
92
+15
| +19% | +$3.1K | ﹤0.01% | 939 |
|
|
2021
Q4 | $18K | Sell |
77
-82
| -52% | -$19.2K | ﹤0.01% | 948 |
|
|
2021
Q3 | $45K | Hold |
159
| – | – | 0.01% | 762 |
|
|
2021
Q2 | $55K | Sell |
159
-456
| -74% | -$158K | 0.01% | 678 |
|
|
2021
Q1 | $172K | Sell |
615
-339
| -36% | -$94.8K | 0.03% | 363 |
|
|
2020
Q4 | $234K | Sell |
954
-464
| -33% | -$114K | 0.04% | 285 |
|
|
2020
Q3 | $402K | Sell |
1,418
-200
| -12% | -$56.7K | 0.08% | 183 |
|
|
2020
Q2 | $433K | Sell |
1,618
-82
| -5% | -$21.9K | 0.09% | 165 |
|
|
2020
Q1 | $538K | Buy |
1,700
+14
| +0.8% | +$4.43K | 0.14% | 127 |
|
|
2019
Q4 | $500K | Buy |
+1,686
| New | +$500K | 0.12% | 150 |
|